Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2010

01-08-2010 | Original Article

Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

Authors: Radha K. Dhiman, Roshan Kurmi, Kiran K. Thumburu, Sunil H. Venkataramarao, Ritesh Agarwal, Ajay Duseja, Yogesh Chawla

Published in: Digestive Diseases and Sciences | Issue 8/2010

Login to get access

Abstract

Background and Aims

Minimal hepatic encephalopathy is the mildest form of the spectrum of hepatic encephalopathy (HE) that impairs health-related quality of life. We assessed (1) the usefulness of psychometric hepatic encephalopathy score and critical flicker frequency for the diagnosis of minimal hepatic encephalopathy, and (2) prognostic significance of minimal hepatic encephalopathy.

Methods

One hundred patients with liver cirrhosis without overt HE were subjected to psychometric hepatic encephalopathy score and critical flicker frequency evaluation. Eighty-three age- and sex-matched healthy volunteers served as controls. Minimal hepatic encephalopathy was diagnosed when the psychometric hepatic encephalopathy score was ≤−5. An age-adjusted Z score <−2 on the critical flicker frequency was considered abnormal.

Results

Forty-eight (48%) patients had minimal hepatic encephalopathy as indicated by altered psychometric hepatic encephalopathy score. Critical flicker frequency was altered in 21 patients; 17 also showed impaired psychometric hepatic encephalopathy score thus providing additional information in only 4 patients. Forty-six of 48 patients with minimal hepatic encephalopathy and 48 of 52 patients without minimal hepatic encephalopathy completed the follow-up. Eighteen (39.1%) patients died among those who had minimal hepatic encephalopathy compared to 11 (22.9%) patients who did not have minimal hepatic encephalopathy. Among the several variables analyzed in this study, univariate analyses showed that age, serum bilirubin level, Child-Turcotte-Pugh score and psychometric hepatic encephalopathy score were associated with a poor prognosis. The multivariate analysis identified two variables as significant independent prognostic factors; psychometric hepatic encephalopathy score ≤−6 [hazard ratio 2.419 (95% CI, 1.014–5.769)] and Child-Turcotte-Pugh score ≥8 [hazard ratio 2.466 (95% CI, 1.010–6.023)] predicted poor survival.

Conclusions

Psychometric hepatic encephalopathy score is a useful tool for the diagnosis of minimal hepatic encephalopathy in an outpatient setting. Both psychometric hepatic encephalopathy score and Child-Turcotte-Pugh score have prognostic value on survival.
Literature
1.
go back to reference Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed
2.
3.
go back to reference Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28:45–49.CrossRefPubMed Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28:45–49.CrossRefPubMed
4.
go back to reference Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agrawal R. Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology. 2007;45:549–559.CrossRefPubMed Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agrawal R. Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology. 2007;45:549–559.CrossRefPubMed
5.
go back to reference Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39:739–745.CrossRefPubMed Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39:739–745.CrossRefPubMed
6.
go back to reference Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology. 2007;45:547–548.CrossRefPubMed Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology. 2007;45:547–548.CrossRefPubMed
7.
go back to reference Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596–604.CrossRefPubMed Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596–604.CrossRefPubMed
8.
go back to reference Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology. 2007;45:833–834.CrossRefPubMed Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology. 2007;45:833–834.CrossRefPubMed
9.
go back to reference Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16:531–535.CrossRefPubMed Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16:531–535.CrossRefPubMed
10.
go back to reference Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–2723.PubMed Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–2723.PubMed
11.
go back to reference Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29:1662–1667.CrossRefPubMed Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29:1662–1667.CrossRefPubMed
12.
go back to reference Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029–2034.CrossRefPubMed Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029–2034.CrossRefPubMed
13.
go back to reference Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773.CrossRefPubMed Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773.CrossRefPubMed
14.
go back to reference Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45:879–885.CrossRefPubMed Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45:879–885.CrossRefPubMed
15.
go back to reference Kurmi R, Dhiman RK, Reddy K, et al. Psychometric hepatic encephalopathy score, critical flicker frequency and p300 event-related potential for the diagnosis of minimal hepatic encephalopathy: evidence that psychometric hepatic encephalopathy score is enough. Indian J Gastroenterol. 2008;27(Suppl 1):51. Kurmi R, Dhiman RK, Reddy K, et al. Psychometric hepatic encephalopathy score, critical flicker frequency and p300 event-related potential for the diagnosis of minimal hepatic encephalopathy: evidence that psychometric hepatic encephalopathy score is enough. Indian J Gastroenterol. 2008;27(Suppl 1):51.
16.
go back to reference Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67–73.CrossRefPubMed Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67–73.CrossRefPubMed
17.
go back to reference Czaja AJ, Freese DK. American Association for the study of liver disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497.CrossRefPubMed Czaja AJ, Freese DK. American Association for the study of liver disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497.CrossRefPubMed
18.
go back to reference Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–1013.CrossRefPubMed Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–1013.CrossRefPubMed
20.
go back to reference Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology. 2006;43:682–689.CrossRefPubMed Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology. 2006;43:682–689.CrossRefPubMed
21.
go back to reference Caldwell SH, Oelsner DH, Iezzoni JC. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;3:664–669.CrossRef Caldwell SH, Oelsner DH, Iezzoni JC. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;3:664–669.CrossRef
22.
go back to reference Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995;10:14–23.CrossRefPubMed Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995;10:14–23.CrossRefPubMed
23.
go back to reference Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357–366.CrossRefPubMed Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357–366.CrossRefPubMed
24.
go back to reference Newcombe R. Two-sided confidence intervals for the single proportion: a comparative evaluation of seven methods. Stat Med. 1998;17:857–872.CrossRefPubMed Newcombe R. Two-sided confidence intervals for the single proportion: a comparative evaluation of seven methods. Stat Med. 1998;17:857–872.CrossRefPubMed
25.
go back to reference Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci. 2000;45:1549–1552.CrossRefPubMed Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci. 2000;45:1549–1552.CrossRefPubMed
26.
go back to reference Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol. 2000;32:748–753.CrossRefPubMed Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol. 2000;32:748–753.CrossRefPubMed
27.
go back to reference Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42(Suppl 1):S45–S53.CrossRefPubMed Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42(Suppl 1):S45–S53.CrossRefPubMed
28.
go back to reference Tarter RE, Sandford SL, Hays AL, Carra JP, Van Thiel DH. Hepatic injury correlates with neuropsychologic impairment. Int J Neurosci. 1989;44:75–82.CrossRefPubMed Tarter RE, Sandford SL, Hays AL, Carra JP, Van Thiel DH. Hepatic injury correlates with neuropsychologic impairment. Int J Neurosci. 1989;44:75–82.CrossRefPubMed
29.
go back to reference Infante-Rivard C, Esnaola S, Villeneuve J-P. Clinical and statistical validity of conventional prognostic factors in predicting shortterm survival among cirrhotics. Hepatology. 1987;7:660–664.CrossRefPubMed Infante-Rivard C, Esnaola S, Villeneuve J-P. Clinical and statistical validity of conventional prognostic factors in predicting shortterm survival among cirrhotics. Hepatology. 1987;7:660–664.CrossRefPubMed
30.
go back to reference Ginés P, Quitero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–128.CrossRefPubMed Ginés P, Quitero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–128.CrossRefPubMed
31.
go back to reference Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39:939–943.CrossRefPubMed Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39:939–943.CrossRefPubMed
32.
go back to reference Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.CrossRefPubMed Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.CrossRefPubMed
33.
go back to reference Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707–1715.CrossRefPubMed Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707–1715.CrossRefPubMed
34.
go back to reference Salmi T. Critical flicker frequencies in MS patients with normal and abnormal pattern VEP. Acta Neurol Scand. 1985;71:354–358.PubMed Salmi T. Critical flicker frequencies in MS patients with normal and abnormal pattern VEP. Acta Neurol Scand. 1985;71:354–358.PubMed
35.
36.
go back to reference Lachenmayr BJ, Kojetinsky S, Ostermaier N, Angstwurm K, Vivell PM, Schaumberger M. The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Ophthalmol Vis Sci. 1994;35:2741–2748.PubMed Lachenmayr BJ, Kojetinsky S, Ostermaier N, Angstwurm K, Vivell PM, Schaumberger M. The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Ophthalmol Vis Sci. 1994;35:2741–2748.PubMed
37.
go back to reference Celesia GG, Daly RF. Effects of aging on visual evoked responses. Arch Nerol. 1977;34:403–407. Celesia GG, Daly RF. Effects of aging on visual evoked responses. Arch Nerol. 1977;34:403–407.
38.
go back to reference Gao H, Hollyfield JG. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1–17.PubMed Gao H, Hollyfield JG. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1–17.PubMed
39.
go back to reference Devaney KO, Johnson HA. Neuron loss in the aging visual cortex of man. J Gerontol. 1980;35:836–841.PubMed Devaney KO, Johnson HA. Neuron loss in the aging visual cortex of man. J Gerontol. 1980;35:836–841.PubMed
40.
go back to reference Balazsi AG, Rootman J, Drance SM, et al. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol. 1984;97:760–766.PubMed Balazsi AG, Rootman J, Drance SM, et al. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol. 1984;97:760–766.PubMed
Metadata
Title
Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver
Authors
Radha K. Dhiman
Roshan Kurmi
Kiran K. Thumburu
Sunil H. Venkataramarao
Ritesh Agarwal
Ajay Duseja
Yogesh Chawla
Publication date
01-08-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1249-7

Other articles of this Issue 8/2010

Digestive Diseases and Sciences 8/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine